Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation. (Q52144637)

23 April 2018

title

Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation. (English)

1 reference

23 April 2018

1 reference

Hannah J Anderson

1

1 reference

23 April 2018

Deni S Galileo

series ordinal

2

1 reference

23 April 2018

publication date

16 February 2016

1 reference

23 April 2018

published in

Cellular Oncology

1 reference

23 April 2018

volume

39

1 reference

23 April 2018

issue

3

1 reference

23 April 2018

page(s)

229-242

1 reference

23 April 2018

Malignant gliomas in adults

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Robust meta-analysis shows that glioma transcriptional subtyping complements traditional approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

The influence of surgery on recurrence pattern of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Extension of neurites on axons is impaired by antibodies against specific neural cell surface glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Differential inhibition of neurone-neurone, neurone-astrocyte and astrocyte-astrocyte adhesion by L1, L2 and N-CAM antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1 mono- and polyclonal antibodies modify cell migration in early postnatal mouse cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1CAM: a major driver for tumor cell invasion and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1 stimulation of human glioma cell motility correlates with FAK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Integrin and neurocan binding to L1 involves distinct Ig domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Signal transduction by focal adhesion kinase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Focal adhesion kinase: in command and control of cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

CAM-FGF receptor interactions: a model for axonal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Automated time-lapse microscopy and high-resolution tracking of cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

FAK in cancer: mechanistic findings and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Targeting FAK in human cancer: from finding to first clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

An alpha5beta1 integrin inhibitor attenuates glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

The Antiangiogenic Effects of Integrin α5β1 Inhibitor (ATN-161) In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Control of motile and invasive cell phenotypes by focal adhesion kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Multiple connections link FAK to cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Molecular targeting of glioblastoma: Drug discovery and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0267-7

Neurite outgrowth patterns in cerebellar microexplant cultures are affected by antibodies to the cell surface glycoprotein L1.

21 January 2018

1 reference

12 December 2020

ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

1 reference

12 December 2020

Biosynthesis and membrane topography of the neural cell adhesion molecule L1.

1 reference

12 December 2020

Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms

1 reference

12 December 2020

Long-term survival of patients with glioblastoma multiforme (GBM).

1 reference

12 December 2020

Comparison of L1 expression and secretion in glioblastoma and neuroblastoma cells

1 reference

12 December 2020

The L1 adhesion molecule supports alpha v beta 3-mediated migration of human tumor cells and activated T lymphocytes

1 reference

12 December 2020

L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma

1 reference

12 December 2020

Structural analysis of the sixth immunoglobulin-like domain of mouse neural cell adhesion molecule L1 and its interactions with alpha(v)beta3, alpha(IIb)beta3, and alpha5beta1 integrins

1 reference

12 December 2020

The L1 adhesion molecule is a cellular ligand for VLA-5

1 reference

12 December 2020

Inhibition of Schwann cell myelination in vitro by antibody to the L1 adhesion molecule

1 reference

12 December 2020

Expression of the neural axon adhesion molecule L1 in the developing and adult rat brain.

1 reference

12 December 2020

Shared cell adhesion molecule (CAM) homology domains point to CAMs signalling via FGF receptors

1 reference

12 December 2020

10.1007/S13402-016-0267-7

Identifiers

DOI

1 reference

23 April 2018

1 reference

23 April 2018